http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3152578-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd670cbd661b958be5910b97ac8cbffb |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B40-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B30-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2015-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb4e59ab54384fbc54df46e5ebbb09af http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4db20c80233b501754a6606399de2d58 |
publicationDate | 2017-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-3152578-A2 |
titleOfInvention | Method and arrays for use in diagnosing early breast cancer |
abstract | The present invention provides a method for diagnosing breast cancer comprising or consisting of the steps of (a) providing a sample to be tested; and (b) determining a biomarker signature of the test sample by measuring the presence and/or amount in the test sample of one or more biomarker selected from the group defined in Table A(i) and/or Table A(ii); wherein the presence and/or amount in the test sample of the one or more biomarker selected from the group defined in Table A(i) and/or Table A(ii) is indicative of the presence of breast cancer cells in the individual, corresponding uses, methods of treating breast cancer, together with arrays and kits for use in the same. |
priorityDate | 2014-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1582.